Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most fre
quent cause of hypoglycaemia in infancy. Clinical presentation is heterogen
eous with variable onset of hypoglycaemia and response to diazoxide, and pr
esence of sporadic or familial forms. Underlying histopathological lesions
can be focal or diffuse. Focal lesions are characterised by focal hyperplas
ia of pancreatic islet-like cells, whereas diffuse lesions implicate the wh
ole pancreas. The distinction between the two forms is important because su
rgical treatment and genetic counselling are radically different Focal lesi
ons correspond to somatic defects which are totally cured by limited pancre
atic resection, whereas diffuse lesions require a subtotal pancreatectomy e
xposing to high risk of diabetes mellitus. Diffuse lesions are due to funct
ional abnormalities involving several genes and different transmission form
s. Recessively inherited PHHI have been attributed to homozygote mutations
for the beta-cell sulfonylurea receptor (SUR1) or the inward-rectifying pot
assium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the
glucokinase gene, particularly when PHHI is associated with diabetes, the g
lutamate dehydrogenase gene when hyperammonaemia is associated, or another
locus. (C) 1998 Elsevier, Paris.